Company intelligence / Profile preview

Kuraya

Ownership: Private
Development stage: Other

Overview

Kura Biotech develops and commercializes innovative enzymatic products for toxicology testing, food safety diagnostics, and genomics applications. Their solutions streamline sample preparation workflows for scientists globally. The company has a strong commitment to sustainability and social impact as a certified B Corporation. Their RESIST Food kit won the PwC Chile Innovative Entrepreneurship Award 2023.

Modalities: EnzymeProtein
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Kuraya.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kuraya.

Explore the full profile